Abnova (Taiwan) Corporation operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abnova (Taiwan) with three other
companies in this sector in Taiwan:
Mycenax Biotech Incorporated
sales of 318.64 million Taiwanese Dollars [US$10.33 million]
of which 98%
was Technical Service Income),
(562.74 million Taiwanese Dollars [US$18.25 million]
of which 99%
was Finished Products Sales), and
Genmont Biotech Inc
(552.94 million Taiwanese Dollars [US$17.93 million]
of which 69%
was Jingyue Company).
During the year ended December of 2017, sales at
Abnova (Taiwan) were 475.07 million Taiwanese Dollars (US$15.41 million).
increase of 8.0%
versus 2016, when the company's sales were 439.83 million Taiwanese Dollars.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Abnova (Taiwan) had sales
of 463.77 million Taiwanese Dollars.